A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

  • STATUS
    Not Recruiting
  • participants needed
    615
  • sponsor
    Pfizer
Updated on 22 January 2022

Summary

Study A0081106 is a 12-month open-label study to evaluate the long term safety and tolerability of pregabalin as add-on therapy in pediatric subjects 1 month to 16 years of age with partial onset seizures and pediatric and adult subjects 5 to 65 years of age with primary generalized tonic-clonic seizures. Pregabalin will be administered in equally divided daily doses for 1 year, in either capsule or liquid oral formulation.

Details
Condition Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures, Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures
Treatment Pregabalin
Clinical Study IdentifierNCT01463306
SponsorPfizer
Last Modified on22 January 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note